Consensus Papers
Vol. 5 No. 4 (2026)
https://doi.org/10.4081/btvb.2026.582

Executive summary of the consensus-based guidance from the SISET (Italian Society for the Study of Hemostasis and Thrombosis) for the management of inferior vena cava thrombosis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 16 October 2026
0
Views
0
Downloads
Venous thromboembolism, inferior vena cava thrombosis, DOAC, low-molecular weight heparins, catheter-directed thrombolysis

Authors

Luca Barcella
ERN EuroBloodNet; Hemostasis and Thrombosis Center, Department of Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Simona Pedrini
Clinical Pathology Unit, Fondazione Poliambulanza University Hospital, Brescia, Italy.
Luca Sarti
Thrombosis Center, Emergency Internal Medicine Unit, Modena University Hospital, Italy.
Monia Marchetti
Hematology and Transplant Unit, University Hospital SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Claudio Sallemi
Interventional Radiology Unit, Fondazione Poliambulanza University Hospital, Brescia, Italy.
Antonella Tufano
Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Walter Ageno
Department of Medicine, University of Padua, Italy.
Marco Marietta
marco.marietta@unimore.it
Department of Hematology, Modena University Hospital, Italy.

We here report a summary of a consensus-based guidance from the Italian Society for the Study of Hemostasis and Thrombosis (SISET) on the management of patients with inferior vena cava thrombosis.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
1.Barcella L, Pedrini S, Sarti L, et al. Management of inferior vena cava thrombosis: guidance from the Italian Society for the Study of Haemostasis and Thrombosis. Thromb Haemost 2026 Jun 30. doi: 10.1055/a-2897-0905. In press.
2.Alkhouli M, Morad M, Narins CR, et al. Inferior vena cava thrombosis. JACC Cardiovasc Interv 2016;9:629-43.
3.Shi W, Dowell JD. Etiology and treatment of acute inferior vena cava thrombosis. Thromb Res 2017;149:9-16.
4.International Society on Thrombosis and Haemostasis. Guidance proposal submission guide. Available from: Available online at: https://www.isth.org/page/GuidanceProposalSub Accessed June 1, 2026.
5.Aziz-Bose R, Margossian R, Ames BL, et al. Delphi panel consensus recommendations for screening and managing childhood cancer survivors at risk for cardiomyopathy. JACC CardioOncol 2022;4:354-67.
6.Kraft C, Hecking C, Schwonberg J, et al. Patients with inferior vena cava thrombosis frequently present with lower back pain and bilateral lower-extremity deep vein thrombosis. Vasa 2013;42:275-83.
7.Gong M, Kong J, Shi Y, et al. Risk factors and a predictive model for nonfilter-associated inferior vena cava thrombosis in patients with lower extremity deep vein thrombosis. Front Cardiovasc Med 2023;9:1083152.
8.Needleman L, Cronan JJ, Lilly MP, et al. Ultrasound for lower extremity deep venous thrombosis: multidisciplinary recommendations from the Society of Radiologists in Ultrasound consensus conference. Circulation 2018;137:1505-15.
9.Shah AA, Buckshee N, Yankelevitz DF, et al. Assessment of deep venous thrombosis using routine pelvic CT. AJR Am J Roentgenol 1999;173:659-63.
10.Evans AJ, Sostman HD, Witty LA, et al. Detection of deep venous thrombosis: prospective comparison of MR imaging and sonography. J Magn Reson Imaging 1996;6:44-51.
11.Linnemann B, Schmidt H, Schindewolf M, et al. Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis. Thromb Res 2008;123:72-8.
12.de la Morena-Barrio ME, Gindele R, Bravo-Pérez C, et al. High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: description of a new syndrome. Am J Hematol 2021;96:1363-73.
13.Olds RJ, Lane DA, Boisclair M, et al. Antithrombin Budapest 3: an antithrombin variant with reduced heparin affinity resulting from the substitution L99F. FEBS Lett 1992; 300:241-6.
14.Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020;4:4693-738.
15.Stevens SM, Woller SC, Baumann Kreuziger L, et al. Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012-2021. Chest 2024;166: 388-404.
16.Cohen O, Ageno W, Farjat AE, et al. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: data from GARFIELD-VTE. J Thromb Haemost 2022;20:366-74.
17.Du J, Nie M, Yan Z, et al. Safety and efficacy of rivaroxaban for inferior vena cava thrombosis after successful catheter-directed thrombolysis. Semin Thromb Hemost 2022;48:459-64.
18.Kearon C, Ageno W, Cannegieter SC, et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016;14:1480-3.
19.Enden T, Kløw NE, Sandvik L, et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009;7: 1268-75.
20.Alkhouli M, Zack CJ, Zhao H, et al. Comparative outcomes of catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of inferior vena caval thrombosis. Circ Cardiovasc Interv 2015;8:e001882.
21.Golowa Y, Warhit M, Matsunaga F, et al. Catheter directed interventions for inferior vena cava thrombosis. Cardiovasc Diagn Ther 2016;6:612-22.
22.Sun X, Qin T, Zhang J, et al. The outcomes of interventional treatment for Budd-Chiari syndrome complicated by inferior vena cava thrombosis: systematic review and meta-analysis. Gastroenterol Hepatol 2021;44:405-17.
23.Morris RI, Jackson N, Smith A, et al. A systematic review of the safety and efficacy of inferior vena cava stenting. Eur J Vasc Endovasc Surg 2023;65:298-308.

Ethics Approval

not requested

CRediT authorship contribution

All the authors read and approved the final version of the manuscript and agreed to be accountable for all aspects of the work.

How to Cite



1.
Barcella L, Pedrini S, Sarti L, Marchetti M, Sallemi C, Tufano A, et al. Executive summary of the consensus-based guidance from the SISET (Italian Society for the Study of Hemostasis and Thrombosis) for the management of inferior vena cava thrombosis. Bleeding Thromb Vasc Biol [Internet]. 2026 Oct. 16 [cited 2026 Oct. 16];5(4). Available from: https://www.btvb.org/btvb/article/view/582
Copyright (c) 2026 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.